IMGENEX is pleased to announce that it has signed an exclusive distribution agreement with Dendritics SAS (Dardilly, France.

San Dieago, CA -- (ReleaseWire) -- 09/10/2007 -- IMGENEXis pleased to announce that it has signed an exclusive distribution agreement with Dendritics SAS (Dardilly, France) to make their portfolio of highly characterized and validated monoclonal Dendritic cell research antibodies available to researchers in North America and India. Founded in 2005, the goal of Dendritics SAS was to make their technology and expertise available to the commercial market where other researchers could benefit from these innovative reagents. Dendritics' reagents have been validated and reported in many peer reviewed publications and can be used in flow cytometric analysis, IHC, cell depletion and blocking assays. All antibodies are purified and most are available in a multiple formats.

Dendritics SAS research reagents are categorized into six major research focus areas: Dendritic Cell (DC) subtypes, C-type Lectin Receptors (CLRs),Toll-like Receptors(TLRs), DC Migration, Cytokines and Cytokine Receptors, Antigen processing & Presentation/ Allergy and include IL7R, pDC/IPC clone 120G8, DCIR, DCLAMP clone 1010E1, DC LAMP clone 104G4, Mouse Langerin.

Visit our Dendritics' product page to obtain technical data on these exciting products. For technical questions, bulk reagent inquiries, or to request your own Dendritics Resource manual, contact us using our Technical Support webpage, email us at info@imgenex.com, or call toll free at 1-800-848-9513

For more information visit: http://www.imgenex.com

Address:
Imgen Corporation
11175 Flintkote Avenue
SAN DIEGO, CA 92121-1318 , US
(858) 642-0978
Fax: 999 999 9999

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

IMGENEX is excited to announce the availability of patient survival data for 25 of their most popular slides.

SAN DIEGO, CA -- (ReleaseWire) -- 09/10/2007 -- IMGENEX is excited to announce the availability of patient survival data for 25 of their most popular slides. This information will enable researchers to identify important prognostic markers and biomarker clusters for characterization of disease progression and patient outcome.

Tissue microarrays (TMA) are a high-throughput method for investigating biomarkers in multiple tissue specimens using multiple techniques including immuno-histo-chemistry, in situ hybridization, FISH and PCR. However, one of the current limitations of this tool is the limited availability of patient survival data which is key to testing the predictive value of relevant biomarkers.

To have complete information regarding Imgenex Corporation's entire selection of Tissue Microarray slides including cancer, normal, and diseased tissues, visit our TMA resource center. Here you can sort by organ, tissue type, species, and specific diagnosis to find a slide matching your precise requirements.

Learn more about our Tissue Microarrays collection and other tissue derivative products by visiting our website http://www.imgenex.com or calling us at 1-800-848-9513.

Address:-
Imgen Corporation
11175 Flintkote Avenue
SAN DIEGO, CA 92121-1318, US
(858) 642-0978 fax: 999 999 9999

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm